Patients diagnosed with type 2 diabetes may have a higher risk of developing cancer, a new study has suggested. The study, ...

Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published ...

A diagnosis of Type 2 diabetes at a young age is much more likely in people who have autism or (ADHD), new research says.

Within five years of their diagnosis, patients with type 2 diabetes have a 33% increased risk of dying or developing kidney ...

The FDA has granted 510(k) clearance for an insulin titration algorithm that uses continuous glucose monitoring and insulin ...

This study aimed to develop a preliminary diabetes-specific Nutritional Literacy (NL) scale and examine its associations with key variables, including HbA1c%. A cross-sectional survey was disseminated ...

Novo Nordisk today announced new retrospective real-world evidence in adults with type 2 diabetes treated with once-weekly ...

Signs of type 2 diabetes can be detected in just a few seconds from the way someone talks, new research being presented at ...

The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly ...

New research has found that higher levels of moderate-to-vigorous physical activity (MVPA) could help reduce the risk of type 2 diabetes in adults.

"TRIUMPH-2 shows what the next generation of cardiometabolic medicine could deliver: substantial weight loss, A1C reduction and improvements across other critical cardiovascular risk factors," said ...